SBRI: Overdose detection, response and intervention - feasibility
OLS and SHIP are investing up to £5 million inclusive of VAT across the two competitions. Their purpose is to develop disruptive, innovative solutions that focus on detecting, responding to, and intervening in, early acute risk of non-fatal and fatal overdose.
This strand is for feasibility study projects which have not yet reached prototype development. The second strand is SBRI: Overdose detection, response and intervention demonstration.
This is phase 1 of a potential 2-phase competition. The decision to proceed to phase 2 will depend on success in phase 1 and the assessment of a separate application.
This competition aims to speed up and improve the detection of, response to and intervention in potentially fatal overdoses using innovative digital technologies and therapeutic solutions.
Projects can focus on one or more of the following priorities:
This list is not intended to be exhaustive.
The potential innovative mechanisms and technologies you can use, include but are not limited to:
At this stage, contracts will be given for phase 1 only.
You must define your goals in your application and outline your plan for phase 2.
In phase 2 Innovate UK will ask successful applicants from phase 1 to deliver a prototype of their solution and demonstrate it in a real-world environment.
Innovate UK encourage proposals that bring together sector specialists and include a co-design and co-production element with the expertise of people:
Your project can focus on one or more of the following themes:
Phase 1: technical feasibility studies
This means planned research or critical investigation to gain new knowledge and skills for developing new products, processes or services.
In phase 1 of your project, you will work closely with the stakeholders to demonstrate the technical feasibility of your proposed innovation and formalise any required ethical approvals, data-sharing agreements and contracts.
Phase 2: prototype development and evaluation
This can include prototyping, demonstrating, piloting, testing and validation of the solution in environments representative of real-life operating conditions.
The outcome of a potential phase 2 will be a demonstration of the prototype in a representative environment.
At this stage, contracts will only be given to successful applicants from phase 1. Progression to a potential phase 2 is dependent on the outcomes from phase 1.
As part of your application, you must engage with a suitable research and innovation partner to serve as a ‘test bed’. The test bed research partner is required to develop your proposed solution, gain relevant clinical and non-clinical advice and determine the extent of required work within the test bed.
Suitable test bed research partners could include the NHS Scotland Regional Test Beds, or equivalents located in England, Wales or Northern Ireland, for example:
You can also propose any other suitable UK-based alternative.
To lead a project, you can: